ACE and ST Elevation Myocardial Infarction: Clinical comorbidities, such as renaldysfunction, ST-elevation myocardial infarction and bradyarrhythmias, were associated with reduced use of ACE inhibitors, calciumchannel blockers and beta-blockers, respectively.